These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23893151)

  • 21. Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancer.
    Johansson H; Aristarco V; Gandini S; Gjerde J; Macis D; Guerrieri-Gonzaga A; Serrano D; Lazzeroni M; Rajasekaran A; Williard CV; Mellgren G; DeCensi A; Bonanni B
    Pharmacogenomics J; 2020 Feb; 20(1):19-26. PubMed ID: 30967597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CYP19A1 gene polymorphisms and risk of lung cancer.
    Zhang J; Yin Y; Niu XM; Liu Y; Garfield D; Chen SF; Wang R; Wang L; Chen HQ
    J Int Med Res; 2013 Jun; 41(3):735-42. PubMed ID: 23669293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haplotype analyses of CYP19A1 gene variants and breast cancer risk: results from the Shanghai Breast Cancer Study.
    Cai Q; Kataoka N; Li C; Wen W; Smith JR; Gao YT; Shu XO; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):27-32. PubMed ID: 18199708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CYP19A1 polymorphisms and clinical outcomes in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial.
    Leyland-Jones B; Gray KP; Abramovitz M; Bouzyk M; Young B; Long B; Kammler R; Dell'Orto P; Biasi MO; Thürlimann B; Lyng MB; Ditzel HJ; Harvey VJ; Neven P; Treilleux I; Rasmussen BB; Maibach R; Price KN; Coates AS; Goldhirsch A; Pagani O; Viale G; Rae JM; Regan MM
    Breast Cancer Res Treat; 2015 Jun; 151(2):373-84. PubMed ID: 25935582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Single Nucleotide Polymorphisms in the CYP19A1 Gene with Female Pattern Hair Loss in a Chinese Population.
    Rui W; Sheng Y; Hu R; Miao Y; Han Y; Guo X; Qi S; Xu F; Xu J; Yang Q
    Dermatology; 2015; 231(3):239-44. PubMed ID: 26228318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphisms in the CYP19A1 (aromatase) gene and endometrial cancer risk in Chinese women.
    Tao MH; Cai Q; Zhang ZF; Xu WH; Kataoka N; Wen W; Xiang YB; Zheng W; Shu XO
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):943-9. PubMed ID: 17507620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of two common single-nucleotide polymorphisms in the CYP19A1 locus and ovarian cancer risk.
    Goodman MT; Lurie G; Thompson PJ; McDuffie KE; Carney ME
    Endocr Relat Cancer; 2008 Dec; 15(4):1055-60. PubMed ID: 18667686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients.
    Fasching PA; Loehberg CR; Strissel PL; Lux MP; Bani MR; Schrauder M; Geiler S; Ringleff K; Oeser S; Weihbrecht S; Schulz-Wendtland R; Hartmann A; Beckmann MW; Strick R
    Breast Cancer Res Treat; 2008 Nov; 112(1):89-98. PubMed ID: 18049890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Research on aromatase gene (CYP19A1) polymorphisms as a predictor of endocrine therapy effectiveness in breast cancer.
    Miron L; Negură L; Peptanariu D; Marinca M
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):997-1004. PubMed ID: 23700878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significant association between common polymorphisms in the aromatase gene CYP19A1 and bone mineral density in postmenopausal women.
    Mullin BH; Carter KW; Lewis JR; Ingley E; Wilson SG; Prince RL
    Calcif Tissue Int; 2011 Dec; 89(6):464-71. PubMed ID: 21952832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between CYP19A1 polymorphisms and sex hormones in postmenopausal Japanese women.
    Kidokoro K; Ino K; Hirose K; Kajiyama H; Hosono S; Suzuki T; Kawase T; Hiraki A; Hamajima N; Tanaka H; Tajima K; Kikkawa F; Matsuo K
    J Hum Genet; 2009 Feb; 54(2):78-85. PubMed ID: 19158807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No associations between aromatase gene polymorphisms and breast cancer risk in Saudi patients.
    Alanazi M; Alabdulkarim HA; Shaik JP; Al Naeem A; Elrobh M; Al Amri A; Al-Mukaynizi FB; Semlali A; Warsy A; Parine NR
    Onco Targets Ther; 2015; 8():2453-9. PubMed ID: 26379441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single nucleotide polymorphisms of CYP19A1 predict clinical outcomes and adverse events associated with letrozole in patients with metastatic breast cancer.
    Park IH; Lee YS; Lee KS; Kim SY; Hong SH; Jeong J; Lee H; Ro J; Nam BH
    Cancer Chemother Pharmacol; 2011 Nov; 68(5):1263-71. PubMed ID: 21442439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of CYP19A1 and CYP1A2 genetic polymorphisms with type 2 diabetes mellitus risk in the Chinese Han population.
    Yang Y; Wang P
    Lipids Health Dis; 2020 Aug; 19(1):187. PubMed ID: 32814585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of linkage disequilibrium patterns and haplotype structure of eight single nucleotide polymorphisms across the CYP1A2 gene between the Korean, and other populations registered in the International HapMap database.
    Woo SW; Kang TS; Park HJ; Lee JE; Roh J
    J Clin Pharm Ther; 2009 Aug; 34(4):429-36. PubMed ID: 19583676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of CYP19A1 gene polymorphisms with anoestrus in water buffaloes.
    El-Bayomi KM; Saleh AA; Awad A; El-Tarabany MS; El-Qaliouby HS; Afifi M; El-Komy S; Essawi WM; Almadaly EA; El-Magd MA
    Reprod Fertil Dev; 2018 Mar; 30(3):487-497. PubMed ID: 28814372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations Between Cytochrome P450 (CYP) Gene Single-Nucleotide Polymorphisms and Second-to-Fourth Digit Ratio in Chinese University Students.
    Zhang J; Yang M; Luan P; Jia W; Liu Q; Ma Z; Dang J; Lu H; Ma Q; Wang Y; Mu C; Huo Z
    Med Sci Monit; 2021 Mar; 27():e930591. PubMed ID: 33723203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic polymorphisms of the CYP19A1 gene and breast cancer survival.
    Long JR; Kataoka N; Shu XO; Wen W; Gao YT; Cai Q; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2115-22. PubMed ID: 17119036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 5α-reductase (SRD5A2) polymorphism is associated with serum testosterone and sex hormone-binding globulin in men, while aromatase (CYP19A1) polymorphisms are associated with oestradiol and luteinizing hormone reciprocally.
    Yeap BB; Knuiman MW; Handelsman DJ; Ho KKY; Hui J; Divitini ML; Arscott GM; McQuillan B; Hung J; Beilby JP
    Clin Endocrinol (Oxf); 2019 Feb; 90(2):301-311. PubMed ID: 30353958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium.
    Travis RC; Schumacher F; Hirschhorn JN; Kraft P; Allen NE; Albanes D; Berglund G; Berndt SI; Boeing H; Bueno-de-Mesquita HB; Calle EE; Chanock S; Dunning AM; Hayes R; Feigelson HS; Gaziano JM; Giovannucci E; Haiman CA; Henderson BE; Kaaks R; Kolonel LN; Ma J; Rodriguez L; Riboli E; Stampfer M; Stram DO; Thun MJ; Tjønneland A; Trichopoulos D; Vineis P; Virtamo J; Le Marchand L; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2734-44. PubMed ID: 19789370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.